You are here: Home :: Area NEM :: Medical science :: Human medicine

Armando Sena, Rui Pedrosa, Véronique Ferret-Sena, Rita Almeida, Maria Lurdes Andrade, Maria Graça Morais, Rémy Couderc

Interferon ?1a Therapy Changes Lipoprotein Metabolism in Patients with Multiple Sclerosis

To assess whether interferon ?1a (IFN?1a) therapy affects plasma lipoprotein metabolism, twelve patients with relapsing-remitting multiple sclerosis (MS) were studied during a two-year follow-up period. High density lipoprotein (Hdl₂) cholesterol and the Hdl₂/Hdl₃ ratio were increased at year 2 and lipoprotein (a) was transitorily increased at year 1, in comparison to baseline levels. Apolipoprotein A-I was lower and apolipoprotein E higher at year 1, only in a subgroup of patients who experienced relapses and/or progressed during therapy. These findings suggest that IFN?1a treatment is associated with changes in the lipoprotein metabolism. Alterations in this metabolism could be related to the immunomodulatory actions of the drug and the disease activity in multiple sclerosis patients.

Clinical Chemical Laboratory Medicine, Walter de Gruyter

Print ISSN: 1434-6621
Volume: 38, 03/2000
Pages: 209 - 213

Show full article (external site)

Show all available items of this journal

 

Area NEM